2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in…

By M. Roffi, C. Patrono, J. Collet, Christian Mueller, M. Valgimigli, F. Andreotti, Jeroen J. Bax, M. Borger, C. Brotons, Derek P. Chew and 9 more. European Heart Journal, 2011

7,411 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/a2181393cf49bee3ed653955f5796906cdf897c6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. P. O'Gara
2. M. Mack
3. L. Fleisher

Citations in the corpus

• COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up (2020, neutral): “20 guidelines should be administered unless there are contraindications (100-103).”
• Fourth Universal Definition of Myocardial Infarction (2018). (2018, neutral): “This treatment may include volume adjustment, blood pressure management, administration of blood products, heart-rate control, and respiratory support.(47,48) Depending on the clinical situation, coronary evaluations may be indicated to assess the likelihood of CAD.”
• 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2016, background): “Issues and recommendations with regard to P2Y12 inhibitor “pretreatment,” “preloading,” and loading are beyond the scope of this document but are addressed in other guidelines (9,14,29).”